-
1
المؤلفون: Cécile Le Péchoux, Anne-Marie C. Dingemans, Laura Mezquita, Boris Duchemann, Emmanuèle Lechapt, Clarisse Audigier-Valette, Clemence Henon, Sophie Cousin, Lizza E.L. Hendriks, Samy Ammari, David Planchard, Anas Gazzah, Corentin Lefebvre, Caroline Caramella, Dirk De Ruysscher, Roberto Ferrara, Julien Mazieres, Angela Botticella, Edouard Auclin, Julien Adam, Audrey Rabeau, Sylvestre Le Moulec, Benjamin Besse
المساهمون: Pulmonologie, Promovendi ODB, MUMC+: MA Med Staf Spec Longziekten (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie
المصدر: Journal of Thoracic Oncology, 14(7), 1244-1254. Elsevier Science
مصطلحات موضوعية: 0301 basic medicine, Male, Lung Neoplasms, Programmed Cell Death 1 Receptor, Pembrolizumab, NSCLC, Gastroenterology, B7-H1 Antigen, 0302 clinical medicine, Antineoplastic Agents, Immunological, Disease specific Graded Prognostic Assessment, Carcinoma, Non-Small-Cell Lung, Checkpoint inhibition, Medicine, Aged, 80 and over, DOCETAXEL, Brain Neoplasms, Middle Aged, Prognosis, OPEN-LABEL, Survival Rate, Oncology, Docetaxel, 030220 oncology & carcinogenesis, Cohort, Carcinoma, Squamous Cell, Female, Nivolumab, medicine.drug, Pulmonary and Respiratory Medicine, Adult, medicine.medical_specialty, Adenocarcinoma of Lung, survival, 03 medical and health sciences, Internal medicine, PATIENTS PTS, Humans, Lung cancer, PEMBROLIZUMAB, Pseudoprogression, Aged, Retrospective Studies, business.industry, Proportional hazards model, NIVOLUMAB, Brain metastases, medicine.disease, EFFICACY, Confidence interval, LIFE, 030104 developmental biology, business, SYSTEM, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f71577960fdcb3b6db9e0ec054f54aa9Test
https://doi.org/10.1016/j.jtho.2019.02.009Test -
2
المؤلفون: Valérie Gounant, Delphine Carmier, Alexandra Langlais, Lionel Uwer, Denis Moro-Sibilot, Franck Morin, Olivier Molinier, José Hureaux, Pierre-Jean Souquet, Patrick Merle, Jean-Louis Pujol, Sébastien Bommart, Clarisse Audigier-Valette, Pierre Mourlanette, Florian Guisier, Aldo Renault, Martine Antoine, Jeannick Madelaine, Laurent Greillier, Marc G. Denis, Audrey Rabeau, J. Otto
المساهمون: Equipe Quantification en Imagerie Fonctionnelle (QuantIF-LITIS), Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Université Le Havre Normandie (ULH), Normandie Université (NU)-Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Normandie Université (NU)
المصدر: Journal of Thoracic Oncology
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2019, 14 (5), pp.903-913. ⟨10.1016/j.jtho.2019.01.008⟩مصطلحات موضوعية: Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Randomization, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Phases of clinical research, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Internal medicine, medicine, Clinical endpoint, Chemotherapy, Humans, Aged, Aged, 80 and over, Programmed cell death ligand 1, business.industry, SCLC, Middle Aged, Small Cell Lung Carcinoma, Confidence interval, 3. Good health, 030104 developmental biology, 030220 oncology & carcinogenesis, Toxicity, Female, Topotecan, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0f0c334a072ea9fa844d16554706157Test
https://doi.org/10.1016/j.jtho.2019.01.008Test -
3
المؤلفون: Pauline Lamoureux, Denis Moro-Sibilot, Thomas Egenod, P. Bombaron, Melinda Daumont, Audrey Rabeau, Adrien Dixmier, Christophe Raspaud, Nicolas Benoit, Didier Debieuvre, N. Ozan, Juliette Dumanoir, Bernard Asselain, Virginie Westeel, C. Calvet, Clarisse Audigier-Valette, Dorothee Reynaud, Victoria Allan, Fabrice Barlesi, François-Emery Cotté, Maurice Pérol, Jean-Bernard Auliac, Jérôme Fayette, Jean-Luc Labourey, Myriam Locatelli Sanchez
المصدر: Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 9, Iss 1 (2020)مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, medicine.medical_specialty, Lung Neoplasms, Immunology, Treatment of lung cancer, EVIDENS, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Immunology and Allergy, Humans, Prospective Studies, Lung cancer, RC254-282, non-small cell lung cancer, nivolumab, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC581-607, medicine.disease, 030104 developmental biology, 030220 oncology & carcinogenesis, Observational study, observational study, France, Immunologic diseases. Allergy, Nivolumab, business, Back Matter
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b3aa8e4cd6d1d9936466474b2b2ea83Test
https://pubmed.ncbi.nlm.nih.gov/33457089Test -
4
المؤلفون: Carlos Gomez-Roca, Delphine Loirat, Bastien Cabarrou, Rodolphe Paulon, Nadia Munsch, Audrey Rabeau, Marie Viala, Jean-Pierre Delord, Thomas Filleron
المصدر: Investigational new drugs. 38(6)
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Immune checkpoint inhibitors, medicine.medical_treatment, Medical Oncology, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, Neoplasms, Medicine, Humans, Pharmacology (medical), In patient, Adverse effect, Immune Checkpoint Inhibitors, Pharmacology, Antitumor activity, Clinical Trials as Topic, business.industry, Clinical trial, Safety profile, 030104 developmental biology, Clinical research, 030220 oncology & carcinogenesis, Immunotherapy, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce22e28f708a83eec6881df03eddc551Test
https://pubmed.ncbi.nlm.nih.gov/32383099Test